Opportunities for new CT contrast agents to maximize the diagnostic potential of emerging spectral CT technologies

BM Yeh, PF FitzGerald, PM Edic, JW Lambert… - Advanced drug delivery …, 2017 - Elsevier
The introduction of spectral CT imaging in the form of fast clinical dual-energy CT enabled
contrast material to be differentiated from other radiodense materials, improved lesion …

Imaging diagnosis and staging of pancreatic ductal adenocarcinoma: a comprehensive review

KY Elbanna, HJ Jang, TK Kim - Insights into imaging, 2020 - Springer
Pancreatic ductal adenocarcinoma (PDAC) has continued to have a poor prognosis for the
last few decades in spite of recent advances in different imaging modalities mainly due to …

[HTML][HTML] Current standards and new innovative approaches for treatment of pancreatic cancer

T Conroy, JB Bachet, A Ayav, F Huguet… - European Journal of …, 2016 - Elsevier
Pancreatic adenocarcinoma remains a devastating disease with a 5-year survival rate not
exceeding 6%. Treatment of this disease remains a major challenge. This article reviews the …

Systematic review of resection rates and clinical outcomes after FOLFIRINOX-based treatment in patients with locally advanced pancreatic cancer

SJ Rombouts, MS Walma, JA Vogel… - Annals of surgical …, 2016 - Springer
Background FOLFIRINOX prolongs survival in patients with metastatic pancreatic cancer
and may also benefit patients with locally advanced pancreatic cancer (LAPC). Furthermore …

Early diagnosis and management of malignant distal biliary obstruction: a review on current recommendations and guidelines

M Fernandez Y Viesca, M Arvanitakis - Clinical and Experimental …, 2019 - Taylor & Francis
Malignant biliary obstruction is a challenging condition, requiring a multimodal approach for
both diagnosis and treatment. Pancreatic adenocarcinoma and cholangiocarcinoma are the …

Current and emerging clinical applications of multispectral optoacoustic tomography (MSOT) in oncology

LR McNally, M Mezera, DE Morgan, PJ Frederick… - Clinical cancer …, 2016 - AACR
Accurate detection and characterization of cancers are key for providing timely intervention
and effective treatments. Current imaging technologies are particularly limited when it comes …

Radiomic features at CT can distinguish pancreatic cancer from noncancerous pancreas

PT Chen, D Chang, H Yen, KL Liu… - Radiology: Imaging …, 2021 - pubs.rsna.org
Purpose To identify distinguishing CT radiomic features of pancreatic ductal
adenocarcinoma (PDAC) and to investigate whether radiomic analysis with machine …

[HTML][HTML] Borderline resectable pancreatic cancer: conceptual evolution and current approach to image-based classification

JW Gilbert, B Wolpin, T Clancy, J Wang, H Mamon… - Annals of oncology, 2017 - Elsevier
Background Diagnostic imaging plays a critical role in the initial diagnosis and therapeutic
monitoring of pancreatic adenocarcinoma. Over the past decade, the concept of 'borderline …

Evaluation of 22G fine-needle aspiration (FNA) versus fine-needle biopsy (FNB) for endoscopic ultrasound-guided sampling of pancreatic lesions: a prospective …

L Tian, AL Tang, L Zhang, XW Liu, JB Li, F Wang… - Surgical …, 2018 - Springer
Background To compare the diagnostic yield and safety of 22G endoscopic ultrasound-
guided fine-needle aspiration (EUS-FNA) and endoscopic ultrasound-guided fine-needle …

Imaging in pancreatic disease

J Dimastromatteo, T Brentnall, KA Kelly - … reviews Gastroenterology & …, 2017 - nature.com
Pancreatic diseases, chronic pancreatitis, pancreatic cancer and diabetes mellitus, taken
together, occur in> 10% of the world population. Pancreatic diseases, as with other …